This Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients With Head and Neck Cancer Who Are Treated With BI 754091
Phase 1 Terminated
8 enrolled 10 charts
Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies
Phase 1 Terminated
17 enrolled
A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
Phase 1 Terminated
10 enrolled
Phase 1b Safety Study of Xevinapant, Weekly Cisplatin, and RT in Participants With Unresected LA SCCHN (HyperlynX)
Phase 1 Terminated
18 enrolled 9 charts
Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors
Phase 1 Terminated
3 enrolled 9 charts
PDL1x41BB
Phase 1 Terminated
160 enrolled
Study of PF-07263689 in Participants With Selected Advanced Solid Tumors
Phase 1 Terminated
13 enrolled 16 charts
A Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
Phase 1 Terminated
127 enrolled
Non-invasive Measurement of PD-L1 Levels With Positron Emission Tomography (PET) in Head and Neck Malignancies and Intracranial Metastases
Phase 1 Terminated
7 enrolled
A Dose Escalation Study of Adavosertib(MK1775) in Combination With 5-FU or 5-FU/CDDP in Patients With Advanced Solid Tumor (1775-005
Phase 1 Terminated
11 enrolled 10 charts
FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors
Phase 1 Terminated
5 enrolled
Safety Study of SEA-CD40 in Cancer Patients
Phase 1 Terminated
159 enrolled
A Study to Evaluate Immune Biomarker Modulation in Response to VTX-2337 in Combination With an Anti- PD-1 Inhibitor in Head and Neck Cancer
Phase 1 Terminated
15 enrolled
Phase I Trial From GRID 18F-FDG-PET Biological Imaging-guided Intensitymodulated Radiotherapy (BG-IMRT) With Patients With Recurrent or New Head or Neck Tumor in Previously Radiated Area
Phase 1 Terminated
12 enrolled
RTX-321 Monotherapy in Patients With HPV 16+ Tumors
Phase 1 Terminated
9 enrolled
DERANO
Phase 1 Terminated
3 enrolled
Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck Cancer
Phase 1 Terminated
4 enrolled
MK-1697-001
Phase 1 Terminated
22 enrolled 18 charts
Hypofractionated Reduced-Volume Chemoradiation for T1/2N0-2 SCC Head and Neck
Phase 1 Terminated
8 enrolled
A Study to Assess the Effects of Multiple Study Drug Regimens in Subjects With Newly Diagnosed Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 1 Terminated
3 enrolled
A Study of DBPR112 in Patients With Head and Neck Cancer and EGFR Mutated Lung Cancer
Phase 1 Terminated
6 enrolled
RAD001, Cisplatin and Concurrent Radiation for Locally Advanced, Inoperable Head and Neck Cancer
Phase 1 Terminated
3 enrolled 6 charts
A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)
Phase 1 Terminated
21 enrolled
Safety Study of SBRT and Docetaxel for Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Head and Neck
Phase 1 Terminated
7 enrolled
VLA-X06
Phase 1 Terminated
4 enrolled
Cetuximab IRDye800 Study as an Optical Imaging Agent to Detect Cancer During Surgical Procedures
Phase 1 Terminated
1 enrolled
MRI in Finding Hypoxia in Patients Undergoing Chemo and Radiation for Head and Neck Cancer
Phase 1 Terminated
10 enrolled
A Phase I Study of Nilontinib and Cetuximab in Patients With Solid Tumors
Phase 1 Terminated
15 enrolled
Dasatinib
Phase 1 Terminated
22 enrolled 8 charts
Safety Study of HPV DNA Vaccine to Treat Head and Neck Cancer Patients
Phase 1 Terminated
2 enrolled
4-HPR and FTI in Head and Neck Squamous Cell Carcinoma (HNSCC)
Phase 1 Terminated
1 enrolled
Tenatumomab
Phase 1 Terminated
2 enrolled
A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer
Phase 1 Terminated
18 enrolled
Azacitidine and Cisplatin in Patients With Advanced Lung or Head and Neck Cancer
Phase 1 Terminated
8 enrolled
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma
Phase 1 Terminated
Study of Pazopanib and Ixabepilone in Patients With Solid Tumors
Phase 1 Terminated
31 enrolled 12 charts
Photodynamic Therapy Using HPPH in Treating Patients With Recurrent Dysplasia, Carcinoma in Situ, or Stage I Oral Cavity Cancer
Phase 1 Terminated
11 enrolled
Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer
Phase 1 Terminated
7 enrolled
Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients With Solid Tumors
Phase 1 Terminated
3 enrolled
Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer
Phase 1 Terminated
35 enrolled
RAD001 With Weekly Cisplatin and Radiation Therapy in Patients With Locally Advanced Head and Neck Cancer
Phase 1 Terminated
3 enrolled
MRX, Radiation, and Chemotherapy for Patients With Resected Squamous Cell Carcinoma of the Head and Neck
Phase 1 Terminated
Exploratory Study of Norepinephrine to Prevent Alopecia in Head and Neck Cancer Patients Treated With Radiotherapy
Phase 1 Terminated
3 enrolled
Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin
Phase 1 Terminated
3 enrolled
Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer
Phase 1 Terminated
18 enrolled